Advancing TB Care: Cutting-Edge Clinical Trials and Statistical Innovations with Patrick Phillips Artwork

The TBPod

The TBPod is a podcast for clinicians and policymakers caring for patients with tuberculosis. The podcasts present discussions with expert clinicians, researchers, policymakers and advocates about their work in the field of tuberculosis. Tuberculosis remains one of the leading causes of death worldwide, and is an important contributor to morbidity among migrants arriving in Australia and New Zealand. There are around 1300 reported cases of TB in Australia each year, and a further 300 in New Zealand. Included in these figures are cases of multi-drug resistant (MDR) TB which pose significant barriers to treatment and management of the disease. The Australian government has committed to the global elimination of TB by 2030, but to do so requires the development of innovative new strategies, based on high-quality research, that has national and international reach. These podcasts aim to engage and update those who are interested in the field of tuberculosis through discussions with leaders in the field of tuberculosis.

All Episodes

The TBPod

Advancing TB Care: Cutting-Edge Clinical Trials and Statistical Innovations with Patrick Phillips

September 01, 2024 • Actnet

Today we had the pleasure of being joined by Associate Professor Patrick Phillips from the University of California, who is the Co-Director of the UC Tuberculosis Research Advancement Center, Clinical & Population Health Science Core. Patrick has a wealth of statistical experience and specialises in the design, implementation, and optimisation of clinical trials for new treatments for drug-sensitive and drug-resistant tuberculosis.

Join us as we explore the rapidly evolving field of TB clinical trials and drug development. Discover the latest advancements in surrogate selection, novel Bayesian phase II designs, and the future of adaptive trial designs. We also delve into the critical clinician-statistician interface, highlighting the exciting opportunities for TB clinicians today.

10.1186/s12879-022-07846-w